Intention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional study

dc.authoridALTAIE, Anmar/0000-0002-2183-6830
dc.authorwosidALTAIE, Anmar/ITV-8235-2023
dc.contributor.authorAl-Taie, Anmar
dc.contributor.authorYilmaz, Zekiye
dc.contributor.authorCakiroglu, Ahmet Yigit
dc.contributor.authorCandan, Gulnihal
dc.contributor.authorBildirici, Selin
dc.date.accessioned2024-05-19T14:39:32Z
dc.date.available2024-05-19T14:39:32Z
dc.date.issued2023
dc.departmentİstinye Üniversitesien_US
dc.description.abstractObjective: To examine the pattern of COVID-19 infection and vaccination, and to explore pregnant women's willingness and reluctance to accept a booster dose of the COVID-19 vaccine.Methods: This was a cross-sectional, descriptive study with a convenient sample size using a structured questionnaire among pregnant women attending the gynecology and obstetrics department at Acibadem Mehmet Ali Aydinlar Hospital, Istanbul, Turkiye. The Health Belief Model scale was used to assess the intention and reluctance to accept a booster dose of the COVID-19 vaccine.Results: A total of 145 participants, with a mean age of (33.5 +/- 4.8) years, and a gestational age of (30.9 +/- 7.3) weeks, were enrolled in this study. 88.8% Received full doses of the Pfizer-BioNTech vaccination. 47.8% Participants suffered from vaccine adverse effects. Health Belief Model demonstrated a significant finding of perceived susceptibility (P<0.001), perceived severity of COVID-19 complications (P<0.001), and perceived benefits regarding a booster COVID-19 vaccination (P<0.001).Conclusions: Most pregnant women who received the COVID-19 immunization express a significant intention to receive a booster dose, regardless of the adverse effects experienced from the previous doses. However, a small percentage of the study sample express hesitancy about receiving the booster dose.en_US
dc.identifier.doi10.4103/2221-6189.388032
dc.identifier.endpage185en_US
dc.identifier.issn2221-6189
dc.identifier.issn2589-5516
dc.identifier.issue5en_US
dc.identifier.startpage179en_US
dc.identifier.urihttps://doi.org10.4103/2221-6189.388032
dc.identifier.urihttps://hdl.handle.net/20.500.12713/4800
dc.identifier.volume12en_US
dc.identifier.wosWOS:001103979600006en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofJournal of Acute Diseaseen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.snmz20240519_kaen_US
dc.subjectBooster Doseen_US
dc.subjectHesitancyen_US
dc.subjectPregnancyen_US
dc.subjectCovid-19en_US
dc.subjectSars-Cov-2en_US
dc.subjectVaccineen_US
dc.titleIntention and hesitancy to receive a booster dose of COVID-19 vaccine among pregnant women using a health belief model: A cross-sectional studyen_US
dc.typeArticleen_US

Dosyalar